Working with aesthetics models: consent, pricing and ethics

A model session is a real treatment on a real patient, and every standard that applies in clinic applies in full: the same medical history, the same consent forms, the same prescriber involvement for prescription-only medicines, the same records. The only things that legitimately differ are the price and the presence of a trainer. Clinics and training environments that treat models as a lower-stakes category, with thinner paperwork and recruitment posts that ignore advertising law, are running their highest-risk treatments under their lowest standards.

What a model session actually is

Models are members of the public who receive treatment at a reduced rate so that a practitioner can build experience, usually in one of three settings: a delegate on a training course injecting under an educator’s supervision, a newly qualified practitioner building case volume with a mentor, or an experienced practitioner learning a new technique or product. In every case the person on the couch is a patient receiving a clinical procedure. Calling them a model changes the commercial arrangement, not the clinical or legal one. The treating practitioner, the supervising clinician and the prescriber each carry the same responsibilities they would for a full-price patient.

Discounted, not free

Charge models a reduced rate rather than nothing. The discount honestly reflects what the model contributes: longer appointment times, a less experienced injector, photography, and the inherent uncertainty of a training environment. But a price, even a modest one, does useful work. It establishes a clear consumer transaction, attracts people who actually want the treatment rather than people drawn by the word free, and reduces the pressure dynamic in which someone feels they cannot withdraw because they are getting something for nothing. Free treatments also sit badly with professional guidance discouraging the use of incentives to promote cosmetic procedures. State the model price plainly in advance, and never let the discount become leverage: a model who hesitates at any point is entitled to stop, keep their money for an unperformed treatment, and leave.

Consent parity is non-negotiable

This is where model sessions most often fall short, and where they must not. Every model completes the same documentation as a full-price patient:

• A full medical history form, screened with the same rigour, with the same contraindications excluding treatment. A model with a contraindication is a person you do not treat, however inconvenient that is for a scheduled course.
• The same procedure-specific consent, for example a botulinum toxin consent form, covering risks, alternatives, and realistic outcomes.
• For prescription-only medicines, the same prescribing process: a face-to-face consultation with the prescriber before treatment, and a prescription for the named patient. Training settings do not dilute this.
• Two additions specific to the setting: written acknowledgement that the treatment will be performed by a trainee or practitioner in supervised training, naming the supervisor, and clarity on who is responsible for follow-up and complication management afterwards, with contact details the model takes home.

Consent must also be revocable in real time. A model can withdraw after the consultation, after the photographs, or with the needle drawn, and the session plan has to absorb that without anyone in the room sighing at them.

Supervision in training settings

If you are the one recruiting models for a course or mentorship, the supervision arrangements are part of what the model is consenting to, so they need to be true. The supervisor should be physically present, able to see the treatment, and ready to intervene or take over, with a sensible ratio of delegates to supervisors. The model should know the trainee’s background and the supervisor’s name before consenting. Complication management drugs and protocols should be in the room, not in theory. If you are a delegate choosing anti-wrinkle injection training, how a provider treats its models is one of the most revealing quality signals available: thin model consent means thin everything else.

Photography consent is separate

Clinical photography happens at model sessions almost by definition, and it needs its own consent, separate from the treatment consent, because the purposes are different. Treatment photographs taken for the clinical record are part of care. Using those same images for marketing, social media, training materials or a portfolio is a different processing purpose requiring its own specific, granular agreement: which images, used where, identifiable or anonymised, for how long, and with a clear statement that the model can refuse marketing use entirely, or withdraw consent later, without affecting their treatment or price. Bundling image rights into the treatment consent, or making marketing consent a condition of the model rate, undermines both documents. Store the signed photography consent with the images, because the question “did she agree to this being posted” tends to arise long after the session.

Recruiting models without breaking advertising law

Botulinum toxin is a prescription-only medicine, and POMs cannot be advertised to the public. That ban catches model recruitment. The Advertising Standards Authority has upheld a complaint against a social media post seeking models that listed Botox among the treatments offered, treating it as an advertisement for a POM in breach of the CAP Code (rule 12.12). A “models wanted for botox” post on a public page or group is, on the ASA’s published approach, an ad for a prescription-only medicine, and the same logic extends to thinly veiled wordings such as anti-wrinkle injections used in a promotional recruitment context.

Recruit instead around the consultation or non-POM framing: models sought for a consultation regarding facial treatments, or for named non-POM procedures, with specifics discussed privately after screening. Dermal fillers are not POMs and may be named, subject to the ordinary rules on responsible advertising. Keep recruitment posts free of before-and-after pressure, time-limited urgency and price-led inducements for medical procedures, all of which attract regulatory attention even outside the POM question.

Safeguarding basics

Finally, the floor beneath all of it. Verify age with ID: under-18s cannot receive cosmetic botulinum toxin or fillers in England, and a training session is no exception. Screen for vulnerability and unrealistic motivation in the consultation, exactly as you would in clinic, and be willing to decline. Never recruit through pressure on staff, students or friends who may feel unable to say no. Give every model a genuine cooling-off gap between recruitment and treatment rather than consenting them on the couch. A model programme run this way produces trained practitioners, fairly treated patients and usable evidence of good governance. Run any other way, it produces the case studies regulators quote.